- Country: Panama
- Summary: Growth Hormone 16 Ui Sf-058-22
- PAT Ref No: 62798139
- Deadline: 08 Feb 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PAB 38340.00
- Notice Type: Tender
- Document Ref. No.: 2022-0-12-18-08-CM-029603
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Law Name: Growth Hormone 16 UI SF-058-22
Type of procedure: Small purchase exceeding B / .10,000 to B / .50,000
Description: Growth hormone 16 UI SF-058-22
Publication date: 02-02-2022 10:31 AM
Date and time Presentation of proposals: 08-02-2022 to 11:00 AM
Opening time and time of the proposal: 08-02-2022 - 11:01 AM
Place of submission of proposals: The presentation of proposals will be electronically, as established in Article 55 of the Sole Text of Law 22, 2006, ordered by Law 153 of 2020. Remedy Date:
Maximum date and time of receipt of expressions of interest:
Reception site:
Reference price: 38340.00
TYPE_OF_AWARD: By Row - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINGrowth Hormone 16 Ui Sf-058-22 - Panama Tender
The MINISTRY OF HEALTH, a Government sector organization in Panama, has announced a new tender for Growth Hormone 16 Ui Sf-058-22. This tender is published on PanamaTenders under PAT Ref No: 62798139 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-02-08.
The estimated tender value is PAB 38340.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
